Home
Random
Nearby
Log in
Settings
Donate
About Wikidata
Disclaimers
Search
(Q36174716)
Watch
English
Affibody-mediated PET imaging of HER3 expression in malignant tumours.
scientific article
In more languages
edit
Statements
instance of
scholarly article
1 reference
stated in
Europe PubMed Central
PMC publication ID
4609989
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26477646%20AND%20SRC:MED&resulttype=core&format=json
retrieved
27 February 2020
title
Affibody-mediated PET imaging of HER3 expression in malignant tumours
(English)
1 reference
stated in
Europe PubMed Central
PMC publication ID
4609989
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26477646%20AND%20SRC:MED&resulttype=core&format=json
retrieved
27 February 2020
author
Bogdan Mitran
series ordinal
3
1 reference
stated in
Europe PubMed Central
PMC publication ID
4609989
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26477646%20AND%20SRC:MED&resulttype=core&format=json
retrieved
27 February 2020
Vladimir Tolmachev
series ordinal
4
1 reference
stated in
Europe PubMed Central
PMC publication ID
4609989
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26477646%20AND%20SRC:MED&resulttype=core&format=json
retrieved
27 February 2020
John Löfblom
series ordinal
5
1 reference
stated in
Europe PubMed Central
PMC publication ID
4609989
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26477646%20AND%20SRC:MED&resulttype=core&format=json
retrieved
27 February 2020
Anna Orlova
series ordinal
6
1 reference
stated in
Europe PubMed Central
PMC publication ID
4609989
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26477646%20AND%20SRC:MED&resulttype=core&format=json
retrieved
27 February 2020
author name string
Maria Rosestedt
series ordinal
1
1 reference
stated in
Europe PubMed Central
PMC publication ID
4609989
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26477646%20AND%20SRC:MED&resulttype=core&format=json
retrieved
27 February 2020
Ken G Andersson
series ordinal
2
1 reference
stated in
Europe PubMed Central
PMC publication ID
4609989
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26477646%20AND%20SRC:MED&resulttype=core&format=json
retrieved
27 February 2020
Stefan Ståhl
series ordinal
7
1 reference
stated in
Europe PubMed Central
PMC publication ID
4609989
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26477646%20AND%20SRC:MED&resulttype=core&format=json
retrieved
27 February 2020
language of work or name
English
0 references
publication date
19 October 2015
1 reference
stated in
Europe PubMed Central
PMC publication ID
4609989
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26477646%20AND%20SRC:MED&resulttype=core&format=json
retrieved
27 February 2020
published in
Scientific Reports
1 reference
stated in
Europe PubMed Central
PMC publication ID
4609989
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26477646%20AND%20SRC:MED&resulttype=core&format=json
retrieved
27 February 2020
volume
5
1 reference
stated in
Europe PubMed Central
PMC publication ID
4609989
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26477646%20AND%20SRC:MED&resulttype=core&format=json
retrieved
27 February 2020
page(s)
15226
1 reference
stated in
Europe PubMed Central
PMC publication ID
4609989
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26477646%20AND%20SRC:MED&resulttype=core&format=json
retrieved
27 February 2020
copyright license
Creative Commons Attribution 4.0 International
start time
19 October 2015
1 reference
stated in
April 2022 Public Data File from Crossref
copyright status
copyrighted
0 references
exact match
https://scigraph.springernature.com/pub.10.1038/srep15226
0 references
cites work
Comparative evaluation of 111In-labeled NOTA‑conjugated affibody molecules for visualization of HER3 expression in malignant tumors.
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4609989
retrieved
1 October 2017
The anti-HER3 antibody patritumab abrogates cetuximab resistance mediated by heregulin in colorectal cancer cells
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4609989
retrieved
1 October 2017
Imaging of CAIX-expressing xenografts in vivo using 99mTc-HEHEHE-ZCAIX:1 affibody molecule
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4609989
retrieved
1 October 2017
Pharmacological targeting of the pseudokinase Her3
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4609989
retrieved
1 October 2017
A role for the pseudokinase HER3 in the acquired resistance against EGFR- and HER2-directed targeted therapy
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4609989
retrieved
1 October 2017
Targeting of erbB3 receptor to overcome resistance in cancer treatment
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4609989
retrieved
1 October 2017
ImmunoPET and biodistribution with human epidermal growth factor receptor 3 targeting antibody ⁸⁹Zr-RG7116
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4609989
retrieved
1 October 2017
Imaging of HER3-expressing xenografts in mice using a (99m)Tc(CO) 3-HEHEHE-Z HER3:08699 affibody molecule.
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4609989
retrieved
1 October 2017
Molecular pathways: HER3 targeted therapy
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4609989
retrieved
1 October 2017
HER3, serious partner in crime: therapeutic approaches and potential biomarkers for effect of HER3-targeting
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4609989
retrieved
1 October 2017
Imaging of platelet-derived growth factor receptor β expression in glioblastoma xenografts using affibody molecule 111In-DOTA-Z09591.
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4609989
retrieved
1 October 2017
Influence of macrocyclic chelators on the targeting properties of (68)Ga-labeled synthetic affibody molecules: comparison with (111)In-labeled counterparts
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4609989
retrieved
1 October 2017
Inhibiting HER3-mediated tumor cell growth with affibody molecules engineered to low picomolar affinity by position-directed error-prone PCR-like diversification
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4609989
retrieved
1 October 2017
In vivo and in vitro studies on renal uptake of radiolabeled affibody molecules for imaging of HER2 expression in tumors
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4609989
retrieved
1 October 2017
[99mTc(CO)3]+-(HE)3-ZIGF1R:4551, a new Affibody conjugate for visualization of insulin-like growth factor-1 receptor expression in malignant tumours
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4609989
retrieved
1 October 2017
Small-animal SPECT/CT of HER2 and HER3 expression in tumor xenografts in athymic mice using trastuzumab Fab-heregulin bispecific radioimmunoconjugates
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4609989
retrieved
1 October 2017
The promise of anti-ErbB3 monoclonals as new cancer therapeutics
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4609989
retrieved
1 October 2017
Imaging of insulinlike growth factor type 1 receptor in prostate cancer xenografts using the affibody molecule 111In-DOTA-ZIGF1R:4551.
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4609989
retrieved
1 October 2017
Imaging of human epidermal growth factor receptor type 2 expression with 18F-labeled affibody molecule ZHER2:2395 in a mouse model for ovarian cancer
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4609989
retrieved
1 October 2017
Non-immunoglobulin based protein scaffolds.
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4609989
retrieved
1 October 2017
Targeting ErbB3: the New RTK(id) on the Prostate Cancer Block
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4609989
retrieved
1 October 2017
Transcriptional and posttranslational up-regulation of HER3 (ErbB3) compensates for inhibition of the HER2 tyrosine kinase
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4609989
retrieved
1 October 2017
Optimal specific radioactivity of anti-HER2 Affibody molecules enables discrimination between xenografts with high and low HER2 expression levels.
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4609989
retrieved
1 October 2017
The role of HER3, the unpretentious member of the HER family, in cancer biology and cancer therapeutics
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4609989
retrieved
1 October 2017
Radiolabelled receptor-tyrosine-kinase targeting drugs for patient stratification and monitoring of therapy response: prospects and pitfalls.
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4609989
retrieved
1 October 2017
Renal toxicity of radiolabeled peptides and antibody fragments: mechanisms, impact on radionuclide therapy, and strategies for prevention
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4609989
retrieved
1 October 2017
Management of breast cancer with targeted agents: importance of heterogeneity. [corrected].
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4609989
retrieved
1 October 2017
Kidney protection during peptide receptor radionuclide therapy with somatostatin analogues
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4609989
retrieved
1 October 2017
Imaging of EGFR expression in murine xenografts using site-specifically labelled anti-EGFR 111In-DOTA-Z EGFR:2377 Affibody molecule: aspect of the injected tracer amount
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4609989
retrieved
1 October 2017
Novel anticancer targets: revisiting ERBB2 and discovering ERBB3.
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4609989
retrieved
1 October 2017
On the selection of a tracer for PET imaging of HER2-expressing tumors: direct comparison of a 124I-labeled affibody molecule and trastuzumab in a murine xenograft model.
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4609989
retrieved
1 October 2017
Targeting ErbB2 and ErbB3 with a bispecific single-chain Fv enhances targeting selectivity and induces a therapeutic effect in vitro
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4609989
retrieved
1 October 2017
Slow internalization of anti-HER2 synthetic affibody monomer 111In-DOTA-ZHER2:342-pep2: implications for development of labeled tracers.
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4609989
retrieved
1 October 2017
The role of ErbB3 and its binding partners in breast cancer progression and resistance to hormone and tyrosine kinase directed therapies
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4609989
retrieved
1 October 2017
68Ga-PET: a powerful generator-based alternative to cyclotron-based PET radiopharmaceuticals
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4609989
retrieved
1 October 2017
New pansomatostatin ligands and their chelated versions: affinity profile, agonist activity, internalization, and tumor targeting
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4609989
retrieved
1 October 2017
First-in-human molecular imaging of HER2 expression in breast cancer metastases using the 111In-ABY-025 affibody molecule.
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4609989
retrieved
23 September 2018
Tumor targeting using affibody molecules: interplay of affinity, target expression level, and binding site composition.
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4609989
retrieved
23 September 2018
Comparative biodistribution of imaging agents for in vivo molecular profiling of disseminated prostate cancer in mice bearing prostate cancer xenografts: focus on 111In- and 125I-labeled anti-HER2 humanized monoclonal trastuzumab and ABY-025 affibod
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4609989
retrieved
23 September 2018
Radionuclide molecular imaging using Affibody molecules
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4609989
retrieved
23 September 2018
HER3 is required for the maintenance of neuregulin-dependent and -independent attributes of malignant progression in prostate cancer cells.
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4609989
retrieved
23 September 2018
68Ga- and 111In-labelled DOTA-RGD peptides for imaging of alphavbeta3 integrin expression
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4609989
retrieved
23 September 2018
Autocrine heregulin generates growth factor independence and blocks apoptosis in colon cancer cells
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4609989
retrieved
23 September 2018
Immuno-SPET/CT and immuno-PET/CT: a step ahead to translational imaging
1 reference
stated in
PubMed
reference URL
https://pubmed.ncbi.nlm.nih.gov/26477646
retrieved
12 December 2020
based on heuristic
inferred from PubMed ID database lookup
Identifiers
DOI
10.1038/SREP15226
1 reference
stated in
Europe PubMed Central
PMC publication ID
4609989
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26477646%20AND%20SRC:MED&resulttype=core&format=json
retrieved
27 February 2020
PMC publication ID
4609989
1 reference
stated in
Europe PubMed Central
PMC publication ID
4609989
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26477646%20AND%20SRC:MED&resulttype=core&format=json
retrieved
27 February 2020
PubMed publication ID
26477646
1 reference
stated in
Europe PubMed Central
PMC publication ID
4609989
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26477646%20AND%20SRC:MED&resulttype=core&format=json
retrieved
27 February 2020
ResearchGate publication ID
283958865
0 references
Sitelinks
Wikipedia
(0 entries)
edit
Wikibooks
(0 entries)
edit
Wikinews
(0 entries)
edit
Wikiquote
(0 entries)
edit
Wikisource
(0 entries)
edit
Wikiversity
(0 entries)
edit
Wikivoyage
(0 entries)
edit
Wiktionary
(0 entries)
edit
Multilingual sites
(0 entries)
edit
